Published in Sarcoma on August 16, 2012
Desmoid tumors complicating Familial Adenomatous Polyposis: a meta-analysis mutation spectrum of affected individuals. BMC Gastroenterol (2015) 0.82
Bone and soft tissue ablation. Semin Intervent Radiol (2014) 0.80
Five years of local control of subscapularis aggressive fibromatosis managed by surgery and imatinib: a case report. J Med Case Rep (2014) 0.75
Recurrent desmoid tumor of the mediastinum: A case report. Oncol Lett (2014) 0.75
Extra-abdominal desmoid tumor located in the axilla. Arch Plast Surg (2014) 0.75
Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5. Cancer Res (2006) 6.66
The role of adherens junctions and VE-cadherin in the control of vascular permeability. J Cell Sci (2008) 4.40
Surgery versus radiation therapy for patients with aggressive fibromatosis or desmoid tumors: A comparative review of 22 articles. Cancer (2000) 4.05
Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumor). J Clin Oncol (2006) 2.81
Prognostic factors influencing progression-free survival determined from a series of sporadic desmoid tumors: a wait-and-see policy according to tumor presentation. J Clin Oncol (2011) 2.60
The enigma of desmoid tumors. Ann Surg (1999) 2.57
Successful chemotherapeutic modality of doxorubicin plus dacarbazine for the treatment of desmoid tumors in association with familial adenomatous polyposis. J Clin Oncol (2006) 2.53
Desmoid-type fibromatosis: a front-line conservative approach to select patients for surgical treatment. Ann Surg Oncol (2009) 2.48
Regulation of lymphoid enhancer factor 1/T-cell factor by mitogen-activated protein kinase-related Nemo-like kinase-dependent phosphorylation in Wnt/beta-catenin signaling. Mol Cell Biol (2003) 2.03
Extra-abdominal desmoid tumors. J Bone Joint Surg Am (1984) 1.89
DESMOID TUMOURS. A SERIES OF 33 CASES. Acta Chir Scand (1963) 1.76
Response of extraabdominal desmoid tumors to therapy with imatinib mesylate. Cancer (2002) 1.75
Quality of surgery and outcome in extra-abdominal aggressive fibromatosis: a series of patients surgically treated at a single institution. J Clin Oncol (2003) 1.68
Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): an FNCLCC/French Sarcoma Group phase II trial with a long-term follow-up. Ann Oncol (2010) 1.58
A nation-wide study comparing sporadic and familial adenomatous polyposis-related desmoid-type fibromatoses. Int J Cancer (2010) 1.56
Imaging of desmoid fibromatosis in pediatric patients. AJR Am J Roentgenol (2002) 1.55
Evaluation of the long term outcome of patients with extremity desmoids. Eur J Surg Oncol (2004) 1.48
Immunohistochemical and molecular analysis of tyrosine kinase activity in desmoid tumors. J Surg Res (2010) 1.44
Current trends in the management of extra-abdominal desmoid tumours. World J Surg Oncol (2006) 1.43
Desmoid tumors: need for an individualized approach. Expert Rev Anticancer Ther (2009) 1.38
Early experience with percutaneous cryoablation of extra-abdominal desmoid tumors. Skeletal Radiol (2009) 1.35
The role of APC and beta-catenin in the aetiology of aggressive fibromatosis (desmoid tumors). Eur J Surg Oncol (2008) 1.35
Cyclooxygenase-two (COX-2) modulates proliferation in aggressive fibromatosis (desmoid tumor). Oncogene (2001) 1.33
Activity of Sorafenib against desmoid tumor/deep fibromatosis. Clin Cancer Res (2011) 1.31
Chemotherapy in patients with desmoid tumors: a study from the French Sarcoma Group (FSG). Ann Oncol (2011) 1.29
Prognostic factors for extra-abdominal and abdominal wall desmoids: a 20-year experience at a single institution. J Surg Oncol (2009) 1.29
Aggressive fibromatosis in children and adolescents: the Italian experience. Cancer (2010) 1.27
Desmoid tumors respond to chemotherapy: defying the dogma in oncology. J Clin Oncol (2005) 1.25
Efficacy of imatinib in aggressive fibromatosis: Results of a phase II multicenter Sarcoma Alliance for Research through Collaboration (SARC) trial. Clin Cancer Res (2010) 1.23
Cyclooxygenase-2 and platelet-derived growth factor receptors as potential targets in treating aggressive fibromatosis. Clin Cancer Res (2007) 1.21
Advanced aggressive fibromatosis: Effective palliation with chemotherapy. Acta Oncol (2010) 1.20
Extra-abdominal desmoid tumors: a report of 234 cases. J Surg Oncol (2010) 1.19
Successful treatment with meloxicam, a cyclooxygenase-2 inhibitor, of patients with extra-abdominal desmoid tumors: a pilot study. J Clin Oncol (2009) 1.18
Low-dose chemotherapy of desmoid tumors. Cancer (1989) 1.17
Desmoid tumors particularly as related to their surgical removal. Ann Surg (1954) 1.15
Vinblastine and methotrexate for desmoid fibromatosis in children: results of a Pediatric Oncology Group Phase II Trial. J Clin Oncol (2007) 1.13
Detection of beta-catenin mutations in paraffin-embedded sporadic desmoid-type fibromatosis by mutation-specific restriction enzyme digestion (MSRED): an ancillary diagnostic tool. Am J Surg Pathol (2007) 1.12
Imaging of superficial and deep fibromatosis. Radiol Med (2009) 1.11
Deep fibromatosis (desmoid tumor): cytopathologic characteristics, clinicoradiologic features, and immunohistochemical findings on fine-needle aspiration. Cancer (2007) 1.11
Gardner's syndrome (familial adenomatous polyposis): a cilia-related disorder. Lancet Oncol (2009) 1.06
Aggressive fibromatosis (desmoid tumor) is derived from mesenchymal progenitor cells. Cancer Res (2010) 1.06
External-beam radiotherapy for pediatric and young adult desmoid tumors. Pediatr Blood Cancer (2010) 1.05
Desmoid tumors: a clinical review of 30 patients with more than 20 years' follow-up. Acta Orthop Scand (2003) 1.05
The management of extra-abdominal desmoid tumours. Int Orthop (2004) 1.01
Musculoskeletal desmoid tumors. J Am Acad Orthop Surg (2008) 0.99
Response of imatinib-resistant extra-abdominal aggressive fibromatosis to sunitinib: case report and review of the literature on response to tyrosine kinase inhibitors. Cancer Chemother Pharmacol (2009) 0.97
Desmoid tumors -- a characterization of patients seen at Mayo Clinic 1976-1999. Fam Cancer (2006) 0.96
Mutations of adenomatous polyposis coli (APC) gene are uncommon in sporadic desmoid tumours. Br J Cancer (1998) 0.96
Desmoids: a revelation in biology and treatment. Ann Surg Oncol (2009) 0.93
Radiation therapy in the treatment of desmoid tumours reduces surgical indications. Eur J Surg Oncol (2009) 0.92
Selective oestrogen receptor modulators in desmoid tumours. Expert Opin Investig Drugs (2004) 0.90
Magnetic resonance imaging in aggressive fibromatosis. Clin Radiol (1990) 0.88
Spontaneous regression of a desmoid tumour. J Bone Joint Surg Br (1986) 0.88
Desmoid tumors. An ultrastructural study of eight cases. Hum Pathol (1980) 0.88
Matrix metalloproteinase activity modulates tumor size, cell motility, and cell invasiveness in murine aggressive fibromatosis. Cancer Res (2004) 0.84
Desmoid tumours of the extremities and trunk: a review of the literature. Int Orthop (2005) 0.84
'Difficult to diagnose' desmoid tumours: a potential role for CTNNB1 mutational analysis. Histopathology (2011) 0.84
[Evaluation of prognostic factors affecting recurrences and disease-free survival in extra-abdominal desmoid tumors]. Acta Orthop Traumatol Turc (2008) 0.83
Abnormalities of the Wnt/β-catenin signalling pathway induce tumour progression in sporadic desmoid tumours: correlation between β-catenin widespread nuclear expression and VEGF overexpression. Histopathology (2011) 0.83
Management of a large abdominal wall desmoid tumor during pregnancy. Case report. Ann Ital Chir (2010) 0.83
The role of postoperative irradiation in the treatment of locally recurrent incompletely resected extra-abdominal desmoid tumors. Sarcoma (2004) 0.82
[Chemotherapy in fibromatoses of childhood and adolescence: results from the Cooperative soft tissue sarcoma study (CWS) and the Italian Cooperative study group (ICG-AIEOP)]. Klin Padiatr (1999) 0.81
[Imaging manifestations and pathologic features of soft tissue desmoid-type fibromatosis]. Ai Zheng (2008) 0.80
The gene for the APC-binding protein beta-catenin (CTNNB1) maps to chromosome 3p22, a region frequently altered in human malignancies. Cytogenet Cell Genet (1995) 0.79
Up-regulation of retinoic acid receptor beta expression in renal cancers in vivo correlates with response to 13-cis-retinoic acid and interferon-alpha-2a. Clin Cancer Res (1999) 1.02
Qa-2 does not display structural genetic polymorphism detectable on isoelectric-focusing gels. Immunogenetics (1982) 0.93
Interleukin 1 beta mediates stress-induced immunosuppression via corticotropin-releasing factor. Endocrinology (1992) 0.88
Corticotropin-releasing factor modulates the immune response to stress in the rat. Endocrinology (1991) 0.87
Immunophenotype of high-grade prostatic adenocarcinoma and urothelial carcinoma. Mod Pathol (2000) 0.85
CDP840. A prototype of a novel class of orally active anti-inflammatory phosphodiesterase 4 inhibitors. Bioorg Med Chem Lett (2002) 0.83
Structural characterization and localization of corticotropin-releasing factor in testis. Biochim Biophys Acta (1989) 0.82
Traumatic lower limb fractures following complete spinal cord injury. Ir Med J (2005) 0.81
Whipple's procedure for an oligometastasis to the pancreas from a leiomyosarcoma of the thigh. Ir J Med Sci (2009) 0.79
Role of corticotropin-releasing factor in immunosuppression. Trans Assoc Am Physicians (1991) 0.77
Plasma catecholamines in acute magnesium deficiency in weanling rats. J Nutr (1986) 0.77
Mesenteric lipodystrophy - An unusual intraabdominal mass. Int J Surg Case Rep (2012) 0.77
Short term neoadjuvant androgen deprivation therapy does not affect prostate specific membrane antigen expression in prostate tissues. Cancer (2000) 0.77
Corticotropin-releasing factor levels in the peripheral plasma and hypothalamus of the rat vary in parallel with changes in the pituitary-adrenal axis. Endocrinology (1988) 0.76
Stress-induced changes in corticotropin-releasing factor (CRF) in immune tissues and hypothalamus: studies toward defining a role for CRF in neuroimmunomodulation. Trans Assoc Am Physicians (1988) 0.75
Splenic laceration following colonoscopy. Ir J Med Sci (2010) 0.75
Book reviews. Popul Stud (Camb) (1980) 0.75
Data organizations and data networks in Minnesota. Am J Med Qual (1996) 0.75
Urine urea nitrogen as measured in the Beckman Astra-8. Clin Chem (1983) 0.75
Hip protectors and the elderly. Ir Med J (2002) 0.75
The LCI system at the Hershey Medical Center. Am J Med Technol (1975) 0.75
Cri du Chat: report of a case. J Commun Disord (1980) 0.75
Asymptomatic thoracic mass nine years after operation for aortic coarctation. Dis Chest (1969) 0.75
Induced abortion in Brazilian married women. Am Lat (1980) 0.75